Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung c... Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. Show more
HAMPTON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that an abstract describing 52 week results from the Companyβs Phase 2 clinical trial...
HAMPTON, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences: 2024...
Phase 3 CSU studies initiated July 2024 Positive topline Phase 2 CIndU 12 week data reported July 2024 supporting Phase 3 advancement 52 week Phase 2 CSU data and full 12 week Phase 2 CIndU data...
Met primary endpoint demonstrating clinically meaningful and statistically significant complete response rate across both dose groupsFirst large, randomized, placebo-controlled study to...
- EMBARQ-CSU1 and EMBARQ-CSU 2 will enroll more than 1800 patients suffering from CSU -- Studies include both biologic naΓ―ve and experienced patients - HAMPTON, N.J., July 16, 2024 (GLOBE...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.52 | -1.24760076775 | 41.68 | 44.8694 | 41.11 | 830351 | 42.21937608 | CS |
4 | 4.8 | 13.201320132 | 36.36 | 45.15 | 35.205 | 690758 | 41.3742886 | CS |
12 | 4.93 | 13.6075075904 | 36.23 | 46.86 | 31.4 | 685448 | 38.60372933 | CS |
26 | 0.1 | 0.2435460302 | 41.06 | 46.86 | 31.4 | 666420 | 38.36476148 | CS |
52 | 14.34 | 53.4675615213 | 26.82 | 53.18 | 22.11 | 753976 | 37.14200795 | CS |
156 | -11.76 | -22.2222222222 | 52.92 | 57.2 | 19.85 | 617211 | 35.41356886 | CS |
260 | 38.61 | 1514.11764706 | 2.55 | 57.2 | 1.5 | 717085 | 26.03636351 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.